Nuwellis Inc vs ProShares UltraPro QQQ ETF — how do they compare? Nuwellis Inc trades at $2.93 (market cap $1.09M), while ProShares UltraPro QQQ ETF trades at $71.14. The key difference: ProShares UltraPro QQQ ETF is trading nearer its 52-week high, Nuwellis Inc nearer its low. Which is the better fit depends on your goals.
| NUWE | TQQQ | |
|---|---|---|
Market Cap | $1.09M | — |
Sector | Technology | Leveraged / Inverse |
52-Week High | $527.46 | $87.22 |
52-Week Low | $2.80 | $37.89 |
Enterprise Value | -$722.58K | — |
Trailing returns across standard periods
Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.
Read more on NUWE →TQQQ is a leveraged ETF that seeks daily investment results, before fees and expenses, that correspond to three times (3x) the daily performance of the Nasdaq-100 Index. It is one of the most liquid and actively traded instruments in the market, designed for sophisticated traders to amplify short-term bullish exposure to large-cap non-financial growth stocks, predominantly in the technology and communication sectors.
Read more on TQQQ →